Medication info
Krelorush Tablets 20mg (Rosuvastatin Calcium)

Krelorush Tablets 20mg (Rosuvastatin Calcium)

Prescription medicationTablet
Ingredient · strength
Rosuvastatin Calcium›20.8mg / 1 tablet
Manufacturer / importer
Sama Pharmaceutical Co., Ltd.
Appearance
Pink round film-coated tablets
Packaging
30 tablets (10 tablets/alu-alu x 3)
Approval status
Active

MFDS item code 201001009 · Notified 2010.01.28

Summary

Main use
Improves dyslipidemia, slows the progression of atherosclerosis, and prevents cardiovascular disease
Who uses it
Adults · Children
Adult dosage
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication and continue it throughout the treatment period. This medication may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased up to a maximum of 20 mg daily. 3. Older adults No dose adjustment is necessary. 4. Patients with renal impairment No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20 mg of this medication to patients with moderate renal impairment. 5. Patients with hepatic impairment No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this medication to patients with active liver disease. 6. Race Because systemic exposure to this medication is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medication is contraindicated in some of these patients.
Children's dosage
2. Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17 years): The usual dose range is 5 mg to 20 mg once daily. (There are no clinical data on doses higher than 20 mg in pediatric patients.) Safety and efficacy have not been established in children under 10 years of age.

Ingredients

Manufacturer
Sama Pharmaceutical Co., Ltd.

Efficacy & effects

Improves dyslipidemia, slows the progression of atherosclerosis, and prevents cardiovascular disease

  • Hypercholesterolemia
  • heterozygous familial hypercholesterolemia
  • mixed hyperlipidemia
  • homozygous familial hypercholesterolemia
  • atherosclerosis
  • dysbetalipoproteinemia
  • primary dyslipoproteinemia
  • increased high-sensitivity C-reactive protein
  • hypertension
  • low HDL cholesterol levels
  • smoking
  • family history of early coronary artery disease
View approved original text

This medication is an adjunct to diet and exercise for patients with primary hypercholesterolemia and mixed hyperlipidemia when these methods are inadequate. It also complements dietary measures for patients with homozygous familial hypercholesterolemia or other lipid-lowering therapies. It is used in patients with hypercholesterolemia to lower total cholesterol and LDL cholesterol to slow the progression of atherosclerosis. In children or adolescents with heterozygous familial hypercholesterolemia, it can be prescribed as a dietary adjunct if their specific LDL cholesterol levels exceed certain values. It is effective in patients with primary dysbetalipoproteinemia and helps reduce the risk of stroke, myocardial infarction, and revascularization procedures in middle-aged individuals at high risk for cardiovascular diseases. Overall, this medication is used to improve blood lipid levels and reduce cardiovascular disease risk.

Dosage and Administration

Adult dosage

1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medication and continue it throughout the treatment period. This medication may be taken at any time of day, with or without food. The initial dose is 5 mg once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to a maintenance dose. The maintenance dose is 10 mg once daily, which is sufficient to control the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and the patient's response; the dose may be increased up to a maximum of 20 mg daily. 3. Older adults No dose adjustment is necessary. 4. Patients with renal impairment No dose adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20 mg of this medication to patients with moderate renal impairment. 5. Patients with hepatic impairment No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function tests should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this medication to patients with active liver disease. 6. Race Because systemic exposure to this medication is increased in Asian patients, the recommended initial dose is 5 mg. Administration of the 40 mg dose is contraindicated. 7. Patients predisposed to myopathy The recommended initial dose for patients predisposed to myopathy is 5 mg. Administration of the 40 mg dose of this medication is contraindicated in some of these patients.

Children's dosage

2. Pediatric patients with heterozygous familial hypercholesterolemia (ages 10 to 17 years): The usual dose range is 5 mg to 20 mg once daily. (There are no clinical data on doses higher than 20 mg in pediatric patients.) Safety and efficacy have not been established in children under 10 years of age.

Precautions

This medication should not be used in certain patients. Firstly, individuals allergic to any ingredients in this drug should not take it. Patients with active liver disease or abnormally elevated liver enzyme levels should avoid this drug. Patients with muscle disease or severely impaired kidney function, and women who are pregnant or breastfeeding should not use this drug. Moreover, patients at high risk of myopathy, especially those taking high doses, should avoid this drug, and caution is needed for those with a family history of genetic muscle disorders, alcohol dependence, or hypothyroidism. This drug contains lactose and is not suitable for patients with lactose intolerance or related hereditary conditions. When administered to patients with a history of excessive alcohol consumption or liver disease, liver function tests should be performed frequently, and patients with hypothyroidism or nephrotic syndrome should treat the underlying condition first. If symptoms of muscle pain or weakness occur, immediate consultation with healthcare professionals is necessary, and blood tests may be needed to assess muscle damage. In cases of acute severe disease or onset of severe muscle weakness, the medication should be discontinued. Also, this medication may increase the risk of muscle-related side effects when taken with certain other drugs, so it is important to consult healthcare professionals about concomitant medications. Patients on high doses should undergo kidney function tests, and Asian patients may require dosage adjustments due to higher drug concentrations. This medication can be used in children and adolescents but impacts on growth and maturation should be monitored. While taking this medication, rare occurrences of liver function abnormalities, skin rash, severe muscle damage, etc., can arise, so any abnormal symptoms should be consulted with healthcare professionals immediately. Women who are pregnant or planning to become pregnant must consult healthcare professionals and use appropriate contraceptive methods. In case of overdose, there is no specific antidote available, and treatment based on symptoms along with liver function and muscle enzyme tests is necessary. Care should be taken when driving or operating machinery as dizziness may occur. Lastly, this drug has been reported to have rare side effects such as interstitial lung disease, so if shortness of breath or persistent cough occurs, immediate consultation with healthcare professionals is necessary.

Side effects

Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, pruritus, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculobulbar weakness, thrombocytopenia, jaundice, hepatitis, elevated transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms, lichenoid drug eruptions, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, fatal and non-fatal liver failure, cognitive impairment, elevated ALT, chest pain, muscle cramps, gout, erectile dysfunction, elevated AST, fatigue, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be kept in a tightly closed container to protect it from air and moisture and stored in a cool place at or below 30 degrees Celsius. This will help to maintain its effectiveness for a longer period.

Appearance and packaging

Appearance

Pink round film-coated tablets

Package unit

30 tablets (10 tablets/alu-alu x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.